Veru sets another quarterly record in both net revenues and in gross profit for fiscal 2021 first quarter

--q1 fy21 net revenues and gross profit of $15m and $11m, respectively, achieve new historical highs for second consecutive quarter-- --late clinical stage oncology drug pipeline focused on prostate and breast cancers continues to advance to registration phase 3 clinical studies--
VERU Ratings Summary
VERU Quant Ranking